The Ensign Group (ENSG)

• Market cap: $7.79B
• 1 day: 0.34%
• 5 days: 5.02%
• 1 month: -2.29%
• 3 months: -8.22%
• 6 months: -1.25%
• Year to date: 2.95%
• 1 year: 18.99%
• 5 years: 187.80%
• 10 years: 526.04%
• Sector: Healthcare
• Industry: Skilled Nursing Care Facilities

About: Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Employees: 35,300

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

643% more call options, than puts

Call options by funds: $8.97M | Put options by funds: $1.21M

147% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 34

15% more funds holding in top 10

Funds holding in top 10: 13 [Q2] → 15 (+2) [Q3]

13% more capital invested

Capital invested by funds: $6.83B [Q2] → $7.7B (+$865M) [Q3]

10% more funds holding

Funds holding: 422 [Q2] → 466 (+44) [Q3]

10% less repeat investments, than reductions

Existing positions increased: 155 | Existing positions reduced: 172

3.07% less ownership

Funds ownership: 97.04% [Q2] → 93.98% (-3.07%) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $155 13% upside
• Avg. target: $167 22% upside
• High target: $175 28% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Truist Securities David Macdonald 59% 1-year accuracy 57 / 96 met price target	13% upside $155	Hold Maintained	6 Jan 2025
UBS A.J. Rice 53% 1-year accuracy 9 / 17 met price target	28% upside $175	Buy Initiated	21 Nov 2024
RBC Capital Ben Hendrix 29% 1-year accuracy 20 / 70 met price target	26% upside $172	Outperform Maintained	28 Oct 2024
Stephens & Co. Scott Fidel 56% 1-year accuracy 22 / 39 met price target	22% upside $167	Overweight Maintained	28 Oct 2024
Oppenheimer Michael Wiederhorn 31% 1-year accuracy 10 / 32 met price target	23% upside $168	Outperform Maintained	25 Oct 2024